Home/Filings/4/0001209191-13-051636
4//SEC Filing

Proto Labs Inc 4

Accession 0001209191-13-051636

$PRLBCIK 0001443669operating

Filed

Nov 11, 7:00 PM ET

Accepted

Nov 12, 4:19 PM ET

Size

14.3 KB

Accession

0001209191-13-051636

Insider Transaction Report

Form 4
Period: 2013-11-08
Cleveland Bradley A.
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2013-11-08$80.46/sh12,565$1,010,980100,155 total(indirect: By Trust)
  • Sale

    Common Stock

    2013-11-08$81.45/sh7,709$627,89892,446 total(indirect: By Trust)
  • Sale

    Common Stock

    2013-11-08$82.68/sh21,115$1,745,78871,331 total(indirect: By Trust)
  • Sale

    Common Stock

    2013-11-08$79.39/sh4,648$369,005112,720 total(indirect: By Trust)
  • Sale

    Common Stock

    2013-11-08$83.57/sh7,096$593,01364,235 total(indirect: By Trust)
Footnotes (6)
  • [F1]Sales effected pursuant to Rule 10b5-1 trading plan adopted by the Bradley A. Cleveland Declaration Trust (the "Trust") on August 30, 2013.
  • [F2]Reflects the weighted average price of 4,648 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 8, 2013 with sale prices ranging from $78.96 to $79.92 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Reflects the weighted average price of 12,565 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 8, 2013 with sale prices ranging from $79.98 to $80.94 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F4]Reflects the weighted average price of 7,709 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 8, 2013 with sale prices ranging from $81.00 to $81.92 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F5]Reflects the weighted average price of 21,115 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 8, 2013 with sale prices ranging from $82.08 to $83.07 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F6]Reflects the weighted average price of 7,096 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 8, 2013 with sale prices ranging from $83.15 to $83.74 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Issuer

Proto Labs Inc

CIK 0001443669

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0001443669

Filing Metadata

Form type
4
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:19 PM ET
Size
14.3 KB